SW
CRSP icon

StrongBox Wealth’s CRISPR Therapeutics CRSP Stock Holding History

StrongBox Wealth’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49K Buy
+64
New +$3.37K ﹤0.01% 256

Other funds holding CRSP

EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
BIP
Bouvel Investment Partners Phoenixville, Pennsylvania $442M AUM 70.77% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

StrongBox Wealth's CRSP Position: Q2 2026 in Review

StrongBox Wealth opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 64 shares worth $3.49K. The stake represents ﹤0.01% of the portfolio and ranks #256 among its holdings.

109 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • StrongBox Wealth held 64 shares of CRISPR Therapeutics worth $3.49K as of Q2 2026.
  • CRISPR Therapeutics was a new StrongBox Wealth position in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of StrongBox Wealth's portfolio in Q2 2026, its #256 holding.
  • 109 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on StrongBox Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.